Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,304 | 58,958 | 33,571 | 64,474 | 64,474 |
| Marketable Securities | 216,548 | 222,219 | 243,575 | 244,667 | 244,667 |
| Receivables | 2,000 | N/A | N/A | N/A | N/A |
| TOTAL | $267,949 | $290,014 | $288,329 | $318,449 | $318,449 |
| Non-Current Assets | |||||
| PPE Net | 16,581 | 18,495 | 17,717 | 17,163 | 17,163 |
| Investments And Advances | 9,882 | 27,463 | 48,449 | 63,879 | 63,879 |
| Other Non-Current Assets | 13,783 | 14,652 | 15,659 | 17,268 | 17,268 |
| TOTAL | $40,246 | $60,610 | $81,825 | $98,310 | $98,310 |
| Total Assets | $308,195 | $350,624 | $370,154 | $416,759 | $416,759 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,187 | 4,525 | 5,629 | 5,064 | 5,064 |
| Accrued Expenses | 21,907 | 18,091 | 15,388 | 22,428 | 22,428 |
| TOTAL | $61,493 | $72,262 | $64,878 | $70,655 | $70,655 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 32,037 | 44,063 | 38,305 | 37,633 | 37,633 |
| Other Non-Current Liabilities | 2,642 | 3,758 | 5,106 | 6,434 | 6,434 |
| TOTAL | $12,885 | $18,441 | $31,224 | $42,408 | $42,408 |
| Total Liabilities | $74,378 | $90,703 | $96,102 | $113,063 | $113,063 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,504 | 48,200 | 47,445 | 47,273 | N/A |
| Common Shares | 49 | 48 | 47 | 47 | 47 |
| Retained earnings | -503,244 | -466,262 | -441,985 | -401,252 | -401,252 |
| Other shareholders' equity | -1,228 | -1,903 | -3,247 | -4,319 | -4,319 |
| TOTAL | $233,817 | $259,921 | $274,052 | $303,696 | $303,696 |
| Total Liabilities And Equity | $308,195 | $350,624 | $370,154 | $416,759 | $416,759 |